Sector: MedicalInovio Biomedical Corporation (AMEX: INO)
Ranking History
Scan Date: | 11/10/2009 |
Sector: | Medical |
Funamental : | 15 |
Technical : | 155 |
Performance : | 52 |
Overall: | 26 |
Number of Stocks: | 306 |
Scan Date: | 11/3/2009 |
Sector: | Medical |
Funamental : | 18 |
Technical : | 174 |
Performance : | 117 |
Overall: | 64 |
Number of Stocks: | 306 |
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 14 |
Technical : | 286 |
Performance : | 59 |
Overall: | 88 |
Number of Stocks: | 306 |
Headlines
- NYSSA Presents 13th Annual Biotech and Specialty Pharmaceuticals Conference
Nov 20, 2009 03:02 PM | CYCC, ECTE, EMIS, INO, PVCT
- Inovio Biomedical Universal Flu Vaccines Demonstrate Broadly Protective Immune Responses Against Multiple Seasonal & Pandemic Influenza Viruses in Pre-Clinical Studies
Nov 20, 2009 06:00 AM | INO
- Inovio Biomedical Universal DNA Vaccine for Chikungunya Virus Demonstrates Protective Antibody Responses in Monkey Model
Nov 18, 2009 06:00 AM | INO
- Therapeutic DNA Vaccine Company Inovio Biomedical Reports Third Quarter 2009 Financial Results
Nov 16, 2009 06:00 AM | INO
- Trading Outlook for Hard To Treat Diseases Inc. Issued by InvestorSoup.com
Nov 13, 2009 06:51 AM | ASTM, CYPB, INO
- Inovio Biomedical to Present at Global Vaccine Conferences
Nov 12, 2009 06:00 AM | INO
- Stocks on the Move: TPIV, INO, MBCI, CRXL
Nov 05, 2009 08:19 AM | CRXL, INO
- Inovio Biomedical Board of Directors Adds Two New Members
Oct 26, 2009 03:00 AM | INO, SNY, WMB
- Trading Review for Inovio Biomedical Corp. Issued by InvestorSoup.com
Oct 21, 2009 06:51 AM | BIIB, GENZ, GILD, INO
- Inovio Biomedical to Present at Investor Conferences
Oct 21, 2009 06:00 AM | INO
- RidgewaterEquity.com Free Fundamental Sector & Market Research on FNM, KGC, HCN, SD, MVL and INO
Nov 09, 2009 08:10 AM | FNM, HCN, INO, KGC, MVL, SD
- Inovio Biomedical and NIH Vaccine Research Center Sign Research Collaboration Agreement to Develop Universal Influenza Vaccines
Aug 10, 2009 03:01 AM | INO
- First Human Demonstration of Significant, Persistent Antibody Response Using Electroporation-Delivered DNA Vaccine Published in Human Gene Therapy
Aug 05, 2009 03:01 AM | INO
- Inovio Closes $30 Million Registered Direct Offering
Jul 31, 2009 01:05 PM | INO
- Inovio Announces $30 Million Registered Direct Offering
Jul 30, 2009 07:47 AM | INO, RODM
- Inovio Biomedical Universal Influenza Vaccines Demonstrate 100% Protection Against Current Pandemic A/H1N1 Influenza Viruses in Animal Studies
Jul 29, 2009 06:04 AM | INO
- Inovio Biomedical Universal Dengue DNA Vaccine Demonstrates Strong Immune Responses Against All Four Serotypes
Jul 27, 2009 06:03 AM | INO
- Inovio Biomedical to Present at Jesup & Lamont Growth Stock Conference
Jul 27, 2009 06:01 AM | INO
- Inovio Biomedical H1N1 Influenza DNA Vaccines Demonstrate 100% Responses Against Swine Flu in Vaccinated Pigs
Jul 13, 2009 01:01 AM | INO
- Inovio Biomedical to Present at International DNA Vaccine Conference
Jul 06, 2009 03:01 AM | INO
- Form 4/A INOVIO BIOMEDICAL CORP For: Nov 16 Filed by: Rassas Kevin (10K)
Nov 18, 2009 02:03 PM
- Form 4 INOVIO BIOMEDICAL CORP For: Nov 16 Filed by: Rassas Kevin (10K)
Nov 18, 2009 01:08 PM
- Form 4 Williams David J For: Oct 26 (10K)
Oct 29, 2009 08:31 PM
- Form 3 Williams David J For: Oct 26 (10K)
Oct 29, 2009 08:30 PM
- Form 4 COLLINS MORTON For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 NG TEE KHIANG For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 BENITO SIMON X For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 Rassas Kevin For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 Sardesai Niranjan For: Sep 30 (10K)
Oct 02, 2009 07:47 PM
- Form 4 Kim Jong Joseph For: Sep 30 (10K)
Oct 02, 2009 07:46 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
INO
|
Compare to S&P
|
| YTD |
194.25 %
|
143.53 %
|
| 4 Weeks |
18.61 %
|
17.33 %
|
| 12 Weeks |
-27.48 %
|
-31.63 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 50.00 %
|
|
EPS Growth in Last Year: 40.00 %
|
|
Sales Growth in Last Quarter: 46.31 %
|
|
Sales Growth in Last Quarter: 701.32 %
|
|
